Inventor

MIYAZONO KOHEI

JP31 patents

⚠️ This page may combine multiple inventors who share the name “MIYAZONO KOHEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MIYAZONO KOHEI

LUDWIG INST CANCER RES

Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use

Isolated, large latent complexes of TGF-β2 and TGF-β3, and new binding protein for latent form TGF-β1, TGF-β2 and TGF-β3 LTBP-2

Substantially pure receptor like TGF-β 1 binding molecules and uses thereof

Activin receptor-like kinases, proteins having serine threonine kinase domains and polynucleotides encoding same

Activin receptor-like kinases, ALK-3 and ALK-6, and nucleic acids encoding them

Isolated, large latent complexes of TGF-β2 and TGF-β3, and new binding protein for latent form TGF-β1, TGF-β2 and TGF-β3 LTBP-2

Isolated nucleic acid encoding receptor-like TGF-β1 binding protein

Isolated nucleic acid molecules which encode activin-receptor like kinases, expression vectors and cells containing these

DNA encoding platelet derived endothelial cell growth factor (PD-ECGF)

Substantially pure receptor like TFG-β1 binding molecules

Antibodies which bind specifically to activin receptor like kinases

Antibodies which bind specifically to activin receptor-like kinases

Activin like receptor--Isolated kinase proteins ALK-2, ALK-4, ALK-5, and nucleic acid molecules encoding them

Peptides derived from endothelial cell growth factor

Isolated nucleotide sequence expressing human transforming growth factor-β1-binding protein

Activin receptor-like kinase-1 proteins having serine-threonine kinase domains

Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use

Recombinant TGF-β type I receptor variants having differentially diminished capacity to signal for matrix protein production

JAPAN FOUND CANCER

Smad6 and uses thereof

Smad6 and uses thereof

Apoptosis-inducing protein and gene encoding the same

Smad6 and uses thereof

Smad6 and uses thereof

CURIS INC

Methods of identifying morphogen receptor-binding analogs

Morphogenic protein-specific cell surface receptors and uses therefor

CREATIVE BIOMOLECULES INC

Methods of antagonizing OP-1 binding to a cell surface receptor utilizing ALK polypeptides

NIPPON SHINYAKU CO LTD

Osteogenesis-promotion enhancer and method of screening the same

KAWASAKI HEAVY IND LTD

Aircraft flight control system including electromechanical actuator

THE UNIV OF TOKYO

Therapeutic and prophylactic agent for glioma, brain tumor malignancy marker, brain tumor prognostic marker, method for determining malignancy and prognosis of brain tumor and antibody inhibiting tumor proliferation

RIKEN

BMP-signal-inhibiting compound

MIYAZONO KOHEI

Antibodies which bind specifically to activin receptor like kinase 3